Antimicrobial resistance (AMR) is one of the top global public health and development threats. According to a 2022 article published in the Lancet, it is estimated that bacterial AMR was directly responsible for 1.27 million global deaths in 2019 and contributed to 4.95 million deaths.
BioInfect will focus on the issues surrounding the increasing threat of AMR and how it can be addressed, including working towards an integrated, unifying approach that aims to achieve optimal and sustainable health outcomes; antimicrobial stewardship; increased investment and innovation in new treatments at all stages of the drug development pipeline and ensuring ROI in the development of new antimicrobials; and the use of strategic information to inform the AMR response.
Events >
AI in Healthcare Symposium Find out more
Join us to discuss how AI is currently being used within healthcare and explore how it's future use is expected to revolutionise the sector
Collaborative Masterclasses: Thriving Cultures Find out more
Embracing learning and growth in the era of psychological safety
Collaborative Masterclasses: Climate Change and the Public Sector Find out more
Bionow BioAI Summit Find out more
Bridging Life Sciences and Artificial Intelligence